---
schema_version: "secwatch.filing_event.v1"
accession: "0001903596-24-000286"
form_type: "8-K"
ticker: "KAYS"
cik: "0001530746"
company_name: "Kaya Holdings, Inc."
filed_at: "2024-05-10T23:59:59+00:00"
generated_at: "2026-06-02T03:39:13.707914+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Kaya Holdings awarded Oregon psilocybin service center license; first guests within 30 days

## Summary
- Oregon Health Authority licenses KAYS to operate The Sacred Mushroom psilocybin treatment center in Portland.
- Facility in historic Falcon Building spans ~11,000 sq ft with private rooms, activity zones, indoor garden.
- KAYS subsidiary Fifth Dimension Therapeutics will operate center; first guests expected within 30 days.
- CEO Craig Frank: company well positioned to become leader in psychedelic 'delivery of care'.
- Precedence Research: U.S. behavioral health market from $83B (2022) to $136B by 2032.

## SEC filing metadata
- accession: 0001903596-24-000286
- form_type: 8-K
- ticker: KAYS
- cik: 0001530746
- company_name: Kaya Holdings, Inc.
- filed_at: 2024-05-10T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530746/000190359624000286/0001903596-24-000286-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530746/000190359624000286/kays_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001903596-24-000286
- JSON: https://secwatch.observer/filing/0001903596-24-000286.json
- Plain text: https://secwatch.observer/filing/0001903596-24-000286.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.